The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Lidbree 42 mg/mL intrauterine gel

Gedeon Richter PlcPA1330/025/001

Main Information

Trade NameLidbree 42 mg/mL intrauterine gel
Active SubstancesLidocaine
Dosage FormIntrauterine gel
Licence HolderGedeon Richter Plc
Licence NumberPA1330/025/001

Group Information

ATC CodeN01BB02 lidocaine


License statusAuthorised
Licence Issued06/11/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back